VCYT insider trading
NasdaqGM HealthcareVERACYTE, INC.: insider trade history from SEC Form 4 filings.
About VERACYTE, INC.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Company website: www.veracyte.com
VCYT insider activity at a glance
FilingIQ tracks 921 insider transactions for VCYT in filings since Jun 30, 2015. The most recent transaction is dated Sep 21, 2026.
Across the full history, 6 open-market purchases
and 370 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VCYT insider trades is 60.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest VCYT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VCYT?
- FilingIQ tracks 921 Form 4 insider transactions for VCYT (VERACYTE, INC.), covering filings from Jun 30, 2015 onwards. 15 of those are dated within the last 90 days.
- Are VCYT insiders net buyers or net sellers?
- Across the full Form 4 history for VCYT, 6 transactions (1%) were open-market purchases and 370 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VCYT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is VCYT in?
- VERACYTE, INC. (VCYT) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $2.83B.
Methodology & sources
Every VCYT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.